Docetaxel Polymeric Micelles clinical trials
How each study uses Docetaxel Polymeric Micelles is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Samyang Biopharmaceuticals Corporation (3) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic agents source
Studies
Open first, then newest update. How each study uses Docetaxel Polymeric Micelles is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast CancerTerminatedPhase 3Samyang Biopharmaceuticals CorporationNCT05207514Written as Nanoxel MHow we know
- A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid TumorsStatus unknownPhase 2Jiangsu Simcere Pharmaceutical Co., Ltd.NCT05254665Written as Docetaxel Polymeric Micelles for InjectionHow we know
- Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBCTerminatedPhase 3Samyang Biopharmaceuticals CorporationNCT02982395Written as Nanoxel®MHow we know
- Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCCStatus unknownPhase 2Samyang Biopharmaceuticals CorporationNCT02639858Written as Docetaxel-PMHow we know